Published in Eye (Lond) on October 01, 2001
Aerobic exercise and intraocular pressure in normotensive and glaucoma patients. BMC Ophthalmol (2009) 0.91
Intraocular pressure and glaucoma: Is physical exercise beneficial or a risk? J Optom (2016) 0.80
Exercise-related visual loss in patients with glaucoma. Eye (Lond) (2003) 0.79
What do glaucoma specialists know about their patients? Graefes Arch Clin Exp Ophthalmol (2005) 0.79
Young adults with advanced glaucoma. Eye (Lond) (2003) 0.75
The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol (2000) 4.59
Function of an ophthalmic "accident and emergency" department: results of a six month survey. Br Med J (Clin Res Ed) (1986) 4.11
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial. Ophthalmology (2001) 2.83
Angle-closure glaucoma in East Asian and European people. Different diseases? Eye (Lond) (2006) 2.31
"Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology (1997) 2.27
ABC of eyes. The red eye. Br Med J (Clin Res Ed) (1988) 1.97
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73
Risk factors for development of post-trabeculectomy endophthalmitis. Br J Ophthalmol (2000) 1.72
A review of trabeculectomy in East Asian people--the influence of race. Eye (Lond) (2005) 1.63
Optic disc changes following trabeculectomy: longitudinal and localisation of change. Br J Ophthalmol (2001) 1.61
Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet (2000) 1.58
Glaucoma drainage devices; past, present, and future. Br J Ophthalmol (1998) 1.55
Choroidal effusions and hypotony caused by severe anterior lens capsule contraction after cataract surgery. Am J Ophthalmol (2000) 1.49
Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci (1998) 1.46
Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol (2004) 1.43
A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma (2004) 1.42
Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study. Br J Ophthalmol (2006) 1.34
Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol (2000) 1.33
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci (1997) 1.28
Problem of dural scarring in recording from awake, behaving monkeys: a solution using 5-fluorouracil. J Neurophysiol (2003) 1.27
Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci (1999) 1.26
TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci (2000) 1.25
Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci (1999) 1.20
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther (2003) 1.17
Defining "occludable" angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people. Br J Ophthalmol (2004) 1.17
A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1998) 1.15
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci (1997) 1.13
Surgery for glaucoma in the 21st century. Br J Ophthalmol (2002) 1.12
Single intraoperative applications of 5-fluorouracil during filtration surgery: early results. Br J Ophthalmol (1994) 1.11
A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Br J Ophthalmol (2001) 1.09
Sponge delivery variables and tissue levels of 5-fluorouracil. Br J Ophthalmol (2000) 1.07
The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol (2000) 1.06
National survey of antimetabolite use in glaucoma surgery in the United Kingdom. Br J Ophthalmol (2004) 1.06
Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol (1992) 1.05
Corneal stem cells in review. Wound Repair Regen (2002) 1.04
Glaucoma filtration surgery using amniotic membrane transplantation. Invest Ophthalmol Vis Sci (2001) 1.04
Aging and the cornea. Br J Ophthalmol (1997) 1.04
Prophylactic laser peripheral iridotomy and cataract progression. Eye (Lond) (2010) 1.03
Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring. Invest Ophthalmol Vis Sci (1999) 1.02
Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol (2000) 1.02
Matrix metalloproteinase distribution during early corneal wound healing. Eye (Lond) (2005) 1.01
An optometrist's role of co-management in a hospital glaucoma clinic. Ophthalmic Physiol Opt (2000) 1.01
Growth factors and ocular wound healing. Eye (Lond) (1994) 1.00
Modulating conjunctival wound healing. Eye (Lond) (2000) 1.00
Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol (2001) 1.00
Beta irradiation: new uses for an old treatment: a review. Eye (Lond) (2003) 0.98
"New" surgical treatments for glaucoma. Br J Ophthalmol (1999) 0.97
Intraoperative 5-fluorouracil for filtration surgery in the rabbit. Invest Ophthalmol Vis Sci (1993) 0.97
The cataract explosion: the changing pattern of diagnoses of patients attending an ophthalmic outpatient department. Eye (Lond) (1991) 0.96
Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol (2000) 0.96
Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction. Invest Ophthalmol Vis Sci (1994) 0.96
MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule. Br J Ophthalmol (2004) 0.96
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Eur J Ophthalmol (2007) 0.94
Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Am J Pathol (2001) 0.94
Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci (1992) 0.94
Tear and serum antibody levels in ocular herpetic infection: diagnostic precision of secretory IgA. Br J Ophthalmol (1986) 0.93
Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies. Drug Discov Today (2010) 0.93
Decrease in adhesion formation by a single application of 5-fluorouracil after flexor tendon injury. Plast Reconstr Surg (1999) 0.93
Compound anterior cranial base fractures: classification using computerized tomography scanning as a basis for selection of patients for dural repair. J Neurosurg (1998) 0.92
The healing optic nerve in glaucoma: transforming growth factor beta and optic nerve head remodelling. Br J Ophthalmol (1999) 0.92
The morphology of the optic nerve head in the Singaporean Chinese population (the Tanjong Pagar study): part 1--Optic nerve head morphology. Br J Ophthalmol (2008) 0.92
Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci (2001) 0.91
Effects of antimetabolite induced cellular growth arrest on fibroblast-fibroblast interactions. Exp Eye Res (1999) 0.91
Correction of lower eyelid retraction in thyroid eye disease: a randomised controlled trial of retractor tenotomy with adjuvant antimetabolite versus scleral graft. Br J Ophthalmol (1998) 0.91
Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma. Eye (Lond) (2004) 0.90
A novel keratocan mutation causing autosomal recessive cornea plana. Invest Ophthalmol Vis Sci (2001) 0.90
Dangers of direct injection of antimetabolites into filtration blebs. Eye (Lond) (1993) 0.89
Is measurement of adult height useful in screening for primary angle closure? Eye (Lond) (2009) 0.88
New model of conjunctival scarring in the mouse eye. Br J Ophthalmol (1998) 0.88
Intraocular pressure and visual field loss in primary angle closure and primary open angle glaucomas. Br J Ophthalmol (2003) 0.88
Surgical results in malignant glaucoma refractory to medical or laser therapy. Eye (Lond) (1997) 0.87
Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Müller stem cell grafts. Exp Eye Res (2009) 0.87
Advances in the management of paediatric glaucoma. Eye (Lond) (2007) 0.87
Meeting the challenge of glaucoma after paediatric cataract surgery. Eye (Lond) (2003) 0.87
T lymphocyte mediated lysis of mitomycin C treated Tenon's capsule fibroblasts. Br J Ophthalmol (2004) 0.86
Human tenon's fibroblast-produced ifnbeta and the prevention of t-cell apoptosis. Invest Ophthalmol Vis Sci (2001) 0.86
Long term growth arrest of human Tenon's fibroblasts following single applications of beta radiation. Br J Ophthalmol (1998) 0.86
Differences in proliferative rate and collagen lattice contraction between endotenon and synovial fibroblasts. J Hand Surg Am (1998) 0.85
Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy. Br J Ophthalmol (1998) 0.85
Understanding and controlling the scarring response: the contribution of histology and microscopy. Microsc Res Tech (1998) 0.85
What is the best primary surgical treatment for the infantile glaucomas? Br J Ophthalmol (1996) 0.84
Temporal stimulation of corneal fibroblast wound healing activity by differentiating epithelium in vitro. Invest Ophthalmol Vis Sci (2000) 0.84
Chiari malformation: CSF flow dynamics in the craniocervical junction and syrinx. Acta Neurochir (Wien) (2005) 0.84
Molecular therapy in ocular wound healing. Br J Ophthalmol (1999) 0.84
T-lymphocyte-fibroblast interactions. Biochem Soc Trans (1997) 0.83
The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts. J Hand Surg Eur Vol (2009) 0.83
Effect of cataract extraction and intraocular lens implantation on nerve fibre layer thickness measurements by scanning laser polarimeter (GDx) in glaucoma patients. Eye (Lond) (2004) 0.83
Cyclodiode photocoagulation for refractory glaucoma after penetrating keratoplasty. Ophthalmology (2001) 0.83
Improving glaucoma filtering surgery. Eye (Lond) (2001) 0.82
The morphology of the optic nerve head in the Singaporean Chinese population (the Tanjong Pagar study): part 2--Biometric and systemic associations. Br J Ophthalmol (2008) 0.82
Otago Glaucoma Surgery Outcome Study: long term results of cataract extraction combined with Molteno implant insertion or trabeculectomy in primary glaucoma. Br J Ophthalmol (2004) 0.81
Spontaneous inferior subconjunctival haemorrhages in association with circumferential drainage blebs. Eye (Lond) (2005) 0.81
Increased mast cell numbers in the conjunctiva of glaucoma patients: a possible indicator of preoperative glaucoma surgery inflammation. Eye (Lond) (2008) 0.81
Wound healing modulation after glaucoma surgery. Curr Opin Ophthalmol (2000) 0.81
Do scleral flap dimensions influence reliability of intraocular pressure control in experimental trabeculectomy? Eye (Lond) (2006) 0.81
Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma. J Obstet Gynaecol (2005) 0.80
Keratinocyte-driven contraction of reconstructed human skin. Wound Repair Regen (2001) 0.80
Visual field loss and Alzheimer's disease. Eye (Lond) (2002) 0.80